Gene · 3055
Papers2,931
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,931
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NIPAL1 Drives a Metabolic-Epigenetic Feedback Loop to Promote Lactate-Mediated Immune Evasion in Esophageal Cancer. | Adv Sci (Weinh) | 2026 | 41816976 | PubTator, text mining | PubMed |
| Deep learning-based real-time seizure detection and multi-seizure classification on pediatric EEG. | Front Neurol | 2026 | 41809189 | PubTator, text mining | PubMed |
| Mechanistic insights into inflammatory cytokines in adenomyosis‑induced infertility (Review). | Int J Mol Med | 2026 | 41789648 | PubTator, text mining | PubMed |
| Exploring the shared gene signatures between rheumatoid arthritis and type 2 diabetes and their implication for drug repositioning on bioinformatics analysis. | Medicine (Baltimore) | 2026 | 41760032 | PubTator, text mining | PubMed |
| Dermal Fibroblasts, Not Keratinocytes, Dominate IL-17A/TNF-Driven Inflammation. | Exp Dermatol | 2026 | 41755670 | PubTator, text mining | PubMed |
Epigenetic Landscape of Female Infertility: An Integrated Bioinformatics Perspective on DNA Methylation, MicroRNAs, and Gene Regulatory Networks Across PCOS, Endometriosis, and Diminished Ovarian Reserve. | Int J Mol Sci | 2026 | 41751922 | PubTator, text mining | PubMed |
| When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia. | Curr Hematol Malig Rep | 2026 | 41741806 | PubTator, text mining | PubMed |
| Editorial: Genetic horizons: exploring genetic biomarkers in therapy and evolution with the aid of artificial intelligence. | Front Genet | 2026 | 41727388 | PubTator, text mining | PubMed |
| The Intersection of m6A Methylation and Immune Response in PCOS: A Bioinformatics Perspective. | Immun Inflamm Dis | 2026 | 41725222 | PubTator, text mining | PubMed |
| Corrigendum to "Knockdown of HCK promotes HREC cell viability and inner blood-retinal barrier integrity by regulating the AMPK signaling pathway". | Open Life Sci | 2026 | 41717541 | PubTator, text mining | PubMed |
| Integrated WGCNA of lncRNA-mRNA Networks Identifies Novel Hub Genes and Potential Therapeutic Agents for Liver Cirrhosis via Molecular Docking Validation. | Int J Mol Sci | 2026 | 41683685 | PubTator, text mining | PubMed |
| Regulation of the HCK-GS-HIF1α axis, a promising druggable target for aggressive TNBC. | Mol Ther | 2026 | 41579866 | PubTator, text mining | PubMed |
| Next-generation CAR-T therapy for acute myeloid leukemia: bridging innovation with clinical translation. | Ann Hematol | 2026 | 41537901 | PubTator, text mining | PubMed |
| DCC-2036 induces repolarization of TAMs to M1 type and enhances CD8+ T cell immunity in TNBC. | Mol Ther | 2026 | 41137391 | PubTator, text mining | PubMed |
| RNAPaceDB: a dedicated database to dissect RNA velocity across diverse cell types. | Nucleic Acids Res | 2026 | 41118514 | PubTator, text mining | PubMed |
| Hyperlipidemia-associated specific modules and hub genes revealed by integrative methods of WGCNA and MetaDE. | Front Genet | 2025 | 41446394 | PubTator, text mining | PubMed |
| Dauricine Inhibits Macrophages M2 Polarization and Regulates the Progression and Ferroptosis via HCK/IDO1 in Urinary Bladder Cancer. | Food Sci Nutr | 2025 | 41438182 | PubTator, text mining | PubMed |
| Targeting the CD47-HCK-LGALS9 axis disrupts proliferation-immunosuppression coupling in early-stage endometrial cancer. | Mol Cancer | 2025 | 41437376 | PubTator, text mining | PubMed |
| DeepKinome: quantitative prediction of kinase binding affinity by a compound using deep learning based regression model. | Front Mol Biosci | 2025 | 41415030 | PubTator, text mining | PubMed |
| Conformational landscape adaptations enable processive phosphorylation by Src family kinases. | Science | 2025 | 41411430 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3055/papers?page=2